z-logo
open-access-imgOpen Access
Relationship Between Exoprotease Secretion and the Synthesis of Ribonucleic Acid and Protein in Bacillus amyloliquefaciens
Author(s) -
G. Coleman,
Samuel Brown
Publication year - 1975
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.7.6.840
Subject(s) - bacillus amyloliquefaciens , bacteria , protein biosynthesis , messenger rna , rna , chloramphenicol , exoenzyme , microbiology and biotechnology , biology , uracil , bacterial growth , secretion , antibiotics , amino acid , biochemistry , chemistry , gene , dna , genetics
Studies with washed bacteria suspended in fresh medium, in which bacterial densities were altered by a factor of four so as to cause accelerated entry of exponential bacteria into the postexponential phase and to re-establish growth in postexponential bacteria, have been performed. Under all the conditions examined rifampin, at a concentration of 0.5 μg/ml, inhibited [14 C]uracil incorporation into total ribonucleic acid (RNA) by 90 to 95%. The percentage of inhibition of incorporation of14 C-labeled amino acids into total protein achieved in parallel experiments was less, being not more than 80%. These results suggested that non-translatable RNA synthesis was inhibited more than messenger RNA (mRNA) by the antibiotic. It was found that on slowing the growth of exponential-phase bacteria exoprotease was formed at a high rate without a lag. It was further observed that when postexponential bacteria were induced to grow, by resuspending them at a lower density, exoprotease mRNA synthesis was switched off. The only synthesis of exoprotease which occurred in this case was accountable to pre-existing mRNA during its decay. Exoenzyme formation was found to be less susceptible to rifampin than total protein synthesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here